Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1991-03-28
1993-03-16
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
546 22, C07F 906, A61K 31675
Patent
active
051944308
ABSTRACT:
The present invention is directed to a class of 3-phosphono-piperidine and pyrrolidine derivatives and their use as NMDA antagonists.
REFERENCES:
patent: 2706194 (1955-04-01), Morris
patent: 3361784 (1968-01-01), Leu
patent: 4132542 (1979-01-01), Aya et al.
patent: 4657899 (1987-04-01), Rzeszotarski et al.
patent: 4746653 (1988-05-01), Hutchison et al.
Cintins Marianne M.
Dixon J. Michael
Kilby Scalzo Catherine S.
Merrell Dow Pharmaceuticals Inc.
LandOfFree
Heterocyclic-NMDA antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic-NMDA antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic-NMDA antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-350657